"Designing Growth Strategies is in our DNA"

Psoriatic Arthritis Treatment Market Size, Share & COVID-19 Impact Analysis, By Drugs Class (Non-steroidal Anti-inflammatory Drugs (NSAIDS), Non-biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs), Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) and Others), By Route of Administration (Oral, Parenteral, and Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Regional Forecast, 2020-2027

Region : Global | Format: PDF | Report ID: FBI101066

 

Table of Content:

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Psoriatic Arthritis for Key Countries/Region
    2. Recent Industry Developments Such as Partnerships, Mergers & Acquisitions, New Product Launches Etc.
    3. Pipeline Analysis for Key Companies
    4. Regulatory Framework by Key Countries
    5. Impact of COVID-19 on Psoriatic Arthritis Treatment Market
  5. Global Psoriatic Arthritis Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Class
      1. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
      2. Non-biologic Disease Modifying Anti-Rheumatic Drugs
      3. Biologic Disease Modifying Anti-Rheumatic Drugs
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Psoriatic Arthritis Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
      2. Non-biologic Disease Modifying Anti-Rheumatic Drugs
      3. Biologic Disease Modifying Anti-Rheumatic Drugs
    3. Market Analysis – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online pharmacies
    5. Market Analysis – By Country
      1. U.S.
      2. Canada
  7. Europe Psoriatic Arthritis Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Non-steroidal Anti-inflammatory Drugs
      2. Non-biologic Disease Modifying Anti-Rheumatic Drugs
      3. Biologic Disease Modifying Anti-Rheumatic Drugs
    3. Market Analysis – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online pharmacies
    5. Market Analysis – By Country/Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Psoriatic Arthritis Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
      2. Non-biologic Disease Modifying Anti-Rheumatic Drugs
      3. Biologic Disease Modifying Anti-Rheumatic Drugs
    3. Market Analysis – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online pharmacies
    5. Market Analysis – By Country/Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Psoriatic Arthritis Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
      2. Non-biologic Disease Modifying Anti-Rheumatic Drugs
      3. Biologic Disease Modifying Anti-Rheumatic Drugs
    3. Market Analysis – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online pharmacies
    5. Market Analysis – By Country/Sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Psoriatic Arthritis Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
      2. Non-biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs)
      3. Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs
    3. Market Analysis – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online pharmacies
    5. Market Analysis – By Country/Sub-region
      1. GCC Countries
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2019)
    3. Company Profiles (Overview, Products, SWOT, Recent developments, strategies, financials (based on availability))
      1. AbbVie Inc.
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. Novartis AG
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. Johnson & Johnson Services, Inc.
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. Pfizer Inc.,
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      5. LEO Pharma A/S
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      6. Merck & Co., Inc.
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      7. Amgen Inc.
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      8. Eli Lilly and Company
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      9. CELGENE CORPORATION
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      10. UCB S.A.
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      11. Sun Pharmaceutical Industries Ltd.
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      12. Other prominent players
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
  12. Strategic Recommendations

List of Figures

Figure 1:  Global Psoriatic Arthritis Treatment Market Revenue Breakdown (USD Billion, %) by Region, 2019 & 2027

Figure 2:  Global Psoriatic Arthritis Treatment Market Value Share (%), by Drug Class, 2019 & 2027

Figure 3:  Global Psoriatic Arthritis Treatment Market Forecast (USD Billion), by Non-Steroidal Anti-inflammatory Drugs (NSAIDS), 2016-2027

Figure 4:  Global Psoriatic Arthritis Treatment Market Forecast (USD Billion), by Non-Biologic Disease Modifying Anti-Rheumatic Drugs, 2016-2027

Figure 5:  Global Psoriatic Arthritis Treatment Market Forecast (USD Billion), by Biologic Disease Modifying Anti-Rheumatic Drugs, 2016-2027

Figure 6:  Global Psoriatic Arthritis Treatment Market Value Share (%), by Route of Administration, 2019 & 2027

Figure 7:  Global Psoriatic Arthritis Treatment Market Forecast (USD Billion), by Oral, 2016-2027

Figure 8:  Global Psoriatic Arthritis Treatment Market Forecast (USD Billion), by Parenteral, 2016-2027

Figure 9:  Global Psoriatic Arthritis Treatment Market Forecast (USD Billion), by Topical, 2016-2027

Figure 10:  Global Psoriatic Arthritis Treatment Market Value Share (%), by Distribution Channel, 2019 & 2027

Figure 11:  Global Psoriatic Arthritis Treatment Market Forecast (USD Billion), by Hospital Pharmacies, 2016-2027

Figure 12:  Global Psoriatic Arthritis Treatment Market Forecast (USD Billion), by Retail Pharmacies, 2016-2027

Figure 13:  Global Psoriatic Arthritis Treatment Market Forecast (USD Billion), by Online Pharmacies, 2016-2027

Figure 14:  Global Psoriatic Arthritis Treatment Market Value (USD Billion), by Region, 2019 & 2027

Figure 15:  North America Psoriatic Arthritis Treatment Market Value (USD Billion), by Drug Class, 2019 & 2027

Figure 16:  North America Psoriatic Arthritis Treatment Market Value Share (%), by Drug Class, 2019

Figure 17:  North America Psoriatic Arthritis Treatment Market Value (USD Billion), by Route of Administration, 2019 & 2027

Figure 18:  North America Psoriatic Arthritis Treatment Market Value Share (%), by Route of Administration, 2019

Figure 19:  North America Psoriatic Arthritis Treatment Market Value (USD Billion), by Distribution Channel, 2019 & 2027

Figure 20:  North America Psoriatic Arthritis Treatment Market Value Share (%), by Distribution Channel, 2019

Figure 21:  North America Psoriatic Arthritis Treatment Market Value (USD Billion), By Country, 2019 & 2027

Figure 22:  North America Psoriatic Arthritis Treatment Market Value Share (%), By Country, 2019

Figure 23:  Europe Psoriatic Arthritis Treatment Market Value (USD Billion), by Drug Class, 2019 & 2027

Figure 24:  Europe Psoriatic Arthritis Treatment Market Value Share (%), by Drug Class, 2019

Figure 25:  Europe Psoriatic Arthritis Treatment Market Value (USD Billion), by Route of Administration, 2019 & 2027

Figure 26:  Europe Psoriatic Arthritis Treatment Market Value Share (%), by Route of Administration, 2019

Figure 27:  Europe Psoriatic Arthritis Treatment Market Value (USD Billion), by Distribution Channel, 2019 & 2027

Figure 28:  Europe Psoriatic Arthritis Treatment Market Value Share (%), by Distribution Channel, 2019

Figure 29:  Europe Psoriatic Arthritis Treatment Market Value (USD Billion), By Country/ Sub-region, 2019 & 2027

Figure 30:  Europe Psoriatic Arthritis Treatment Market Value Share (%), By Country/ Sub-region, 2019

Figure 31:  Asia Pacific Psoriatic Arthritis Treatment Market Value (USD Billion), by Drug Class, 2019 & 2027

Figure 32:  Asia Pacific Psoriatic Arthritis Treatment Market Value Share (%), by Drug Class, 2019

Figure 33:  Asia Pacific Psoriatic Arthritis Treatment Market Value (USD Billion), by Route of Administration, 2019 & 2027

Figure 34:  Asia Pacific Psoriatic Arthritis Treatment Market Value Share (%), by Route of Administration, 2019

Figure 35:  Asia Pacific Psoriatic Arthritis Treatment Market Value (USD Billion), by Distribution Channel, 2019 & 2027

Figure 36:  Asia Pacific Psoriatic Arthritis Treatment Market Value Share (%), by Distribution Channel, 2019

Figure 37:  Asia Pacific Psoriatic Arthritis Treatment Market Value (USD Billion), By Country/ Sub-region, 2019 & 2027

Figure 38:  Asia Pacific Psoriatic Arthritis Treatment Market Value Share (%), By Country/ Sub-region, 2019

Figure 39:  Latin America Psoriatic Arthritis Treatment Market Value (USD Billion), by Drug Class, 2019 & 2027

Figure 40:  Latin America Psoriatic Arthritis Treatment Market Value Share (%), by Drug Class, 2019

Figure 41:  Latin America Psoriatic Arthritis Treatment Market Value (USD Billion), by Route of Administration, 2019 & 2027

Figure 42:  Latin America Psoriatic Arthritis Treatment Market Value Share (%), by Route of Administration, 2019

Figure 43:  Latin America Psoriatic Arthritis Treatment Market Value (USD Billion), by Distribution Channel, 2019 & 2027

Figure 44:  Latin America Psoriatic Arthritis Treatment Market Value Share (%), by Distribution Channel, 2019

Figure 45:  Latin America Psoriatic Arthritis Treatment Market Value (USD Billion), By Country/ Sub-region, 2019 & 2027

Figure 46:  Latin America Psoriatic Arthritis Treatment Market Value Share (%), By Country/ Sub-region, 2019

Figure 47:  Middle East & Africa Psoriatic Arthritis Treatment Market Value (USD Billion), by Drug Class, 2019 & 2027

Figure 48:  Middle East & Africa Psoriatic Arthritis Treatment Market Value Share (%), by Drug Class, 2019

Figure 49:  Middle East & Africa Psoriatic Arthritis Treatment Market Value (USD Billion), by Route of Administration, 2019 & 2027

Figure 50:  Middle East & Africa Psoriatic Arthritis Treatment Market Value Share (%), by Route of Administration, 2019

Figure 51:  Middle East & Africa Psoriatic Arthritis Treatment Market Value (USD Billion), by Distribution Channel, 2019 & 2027

Figure 52:  Middle East & Africa Psoriatic Arthritis Treatment Market Value Share (%), by Distribution Channel, 2019

Figure 53:  Middle East & Africa Psoriatic Arthritis Treatment Market Value (USD Billion), By Country/ Sub-region, 2019 & 2027

Figure 54:  Middle East & Africa Psoriatic Arthritis Treatment Market Value Share (%), By Country/ Sub-region, 2019

Figure 55:  Global Psoriatic Arthritis Treatment Market Share (%), By Company, 2019

List of Tables

Table 1:  Global Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Drug Class, 2016–2027

Table 2:  Global Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Route of Administration, 2016–2027

Table 3:  Global Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Distribution Channel, 2016–2027

Table 4:  Global Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Region, 2016-2027

Table 5:  North America Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Drug Class, 2016-2027

Table 6:  North America Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Route of Administration, 2016-2027

Table 7:  North America Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Distribution Channel, 2016-2027

Table 8:  North America Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, By Country, 2016-2027

Table 9:  Europe Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Drug Class, 2016-2027

Table 10:  Europe Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Route of Administration, 2016-2027

Table 11:  Europe Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Distribution Channel, 2016-2027

Table 12:  Europe Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2016-2027

Table 13:  Asia Pacific Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Drug Class, 2016-2027

Table 14:  Asia Pacific Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Route of Administration, 2016-2027

Table 15:  Asia Pacific Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Distribution Channel, 2016-2027

Table 16:  Asia Pacific Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2016-2027

Table 17:  Latin America Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Drug Class, 2016-2027

Table 18:  Latin America Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Route of Administration, 2016-2027

Table 19:  Latin America Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Distribution Channel, 2016-2027

Table 20:  Latin America Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2016-2027

Table 21:  Middle East & Africa Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Drug Class, 2016-2027

Table 22:  Middle East & Africa Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Route of Administration, 2016-2027

Table 23:  Middle East & Africa Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Distribution Channel, 2016-2027

Table 24:  Middle East & Africa Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2016-2027

 class=
  • Sep, 2020
  • 2019
  • 2016-2018
  • 160

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Healthcare Clients

DUPONT
Abbott
baxter
lpsos
Logo_Merck_KGaA_2015
chong-kun-dang
DAEWOONG
Natus-Medical
SUANFARMA
Bio-Rad
Intuitive_Surgical_logo
novo-nordisk
Ge-Healthcare
Sedana-Cyan-Black-Tag

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X